Publications produced by the EDRN investigators.
The following is a list of publications authored by EDRN investigators. You may sort and filter the results by both author and journal.
. Deregulated EGFR signaling during lung cancer progression: Mutations, amplicons, and autocrine loops
—Minna JD, Gazdar AF
. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
—Chia D, Pietras R, Zhang L, Yoon N, Goodglick L., Horvath S, Bagryanova L, Maresh EL, Fishbein MC, Marquez D, Mah V, Alavi M
. Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
—Chia D, Sulur G, Yoon NK, Elshimali Y, Goodglick L., Seligson DB, Horvath S, Bonavida B, Li A, Mah V, Maresh E, Bose S
2-D or not 2-D is there a fututre for 2-D gels in proteomics? Insights from the York proteomic meeting
2D Differential In-gel Electrophoresis (DIGE) for the Identification of Esophageal Squamous Cell Cancer-Specific Protein Markers
—Petricoin III EF, Hu N, Flaig M, Li H, Shu H, Taylor PR, Chen S, Gillespie JW, Liotta LA, Zhao Y, DeCamp D, Gong Y, Emmert-Buck MR, Zhou G
4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene
—Hu W, Feng Z, Tang M-s, Beland FA, Rom WN
[-2]proPSA for prostate cancer detection: an NCI Early Detection Research Network validation study.
—Feng Z, Thompson IM, Sokoll LJ, Sanda MG, Wang Y, Kagan J, Chan DW, Partin AW
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.
A data-analytic strategy for protein-biomarker discovery: profiling of high-dimensional proteomic data for cancer detection
—Feng Z, Thornquist M, Winget M, Qu Y, Yasui Y, Adam B-L, Potter JD, Thompson ML, Pepe M, Wright G Jr
A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis
—Hanash SM and Beretta L, Brechot C, Brichory F, Misek DE, Le Naour F
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
—Lynch HT, van der Klift H, Wijnen J, Fodde R, Hampel H, Coronel SM, Sweet K, Wagnr A, Okimoto R, de la Chapelle A, Franken P, Barrows A, Lynch JF
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
A functional annotation of subproteomes in human plasma
—Vondriska TM, Schulz-Knappe P, Menon R, Yang Z, Drwal G, Wu H, Gronborg M, Hancock WS, Raftery M, Shet AS, Rekha B, Gerszten RE, Peri S, Molina H, Chaerkady R, Ping P, Cho SY, Hanash SM, Creighton CJ, Pandey A, Omenn GS, States DJ, Kwon MS, Wasinger V, Kellmann M, Gandhi TK, Paik YK, Suresh S
A functional arginine residue in NADPH-dependent aldehyde reductase from pig kidney.
A functional link between adhesion and proteolysis in ovarian epithelial ovarian carcinoma cells
—Stack MS, Bafetti LM, Fishman DA, Kearns A
A genetic analysis of extinction: Trans-dominant loci regulate expression of liver-specific genes in hepatoma hybrid cells
—Fournier REK, Killary AM
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
—Naylor SL, Garcia DK, Minna JD, Xiang R-H, Buchhagen D, Killary AM, Daly MC, Hensel CH
A lung cancer protein database
—Beer, Tra, D. and Hanash S, Brichory, Puravs, J., E., Oh, F.